Feast track
David Miller, co-founder and CEO of Seattle-based Biotech Stock ....."They make it look like the FDA only chooses for Fast Track those drugs that are important and have a good chance, and that's just not the case because the FDA will Fast Track most anything.................. Reni Benjamin, senior biotech analyst with Rodman & Renshaw, a New York investment banking firm," Benjamin said. "A Fast Track designation, frankly, is noise and an opportunity to take some profit." https://blog.cleveland.com/pdworld/2007/12/_a_decade_ago_the.html